Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy

Clinical trial NCT03330353 · UNKNOWN

Trial details

NCT number: NCT03330353
Sponsor: Massachusetts General Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

PSP - Progressive Supranuclear Palsy PD - Parkinson's Disease AD - Alzheimer's Disease ALS (Amyotrophic Lateral Sclerosis)

Start date: 2017-11-01
Primary completion: 2019-10-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.